Abstract:The mechanisms and risk factors underlying ovarian cancer (OC) remain under investigation, making the identification of new prognostic biomarkers and improved predictive factors critically important. Recently, circulating metabolites have shown potential in predicting survival outcomes and may be associated with the pathogenesis of OC. However, research into their genetic determinants is limited, and there are some inadequacies in understanding the distinct subtypes of OC. In this context, we conducted a Mendelian randomization study aiming to provide evidence for the relationship between genetically determined metabolites (GDMs) and the risk of OC and its subtypes.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the causal effects of various metabolites on ovarian cancer (OC) and its different subtypes. Specifically, the study aims to evaluate the causal relationship between genetically determined metabolites (GDMs) and the risk of ovarian cancer through two - sample Mendelian Randomization (MR) analysis, and further explore the mechanism of action of these metabolites in different subtypes of ovarian cancer. ### Research Background Ovarian cancer (OC) is one of the most challenging gynecological malignancies. Due to the atypical early symptoms and lack of specific detection methods, patients often miss the best treatment opportunity. In addition, there are deficiencies in the identification of prognostic markers and targeted drugs for ovarian cancer, resulting in a high recurrence rate and drug resistance, and poor prognosis for patients. The occurrence of ovarian cancer is a complex multi - factor process, and possible reasons include abnormal ovulation cycles, chronic inflammation of the fallopian tubes, and gene mutations (such as BRCA1). Among them, metabolic dysregulation is considered one of the important contributing factors. ### Research Objectives 1. **Evaluate Causal Relationships**: Evaluate the causal relationships between 486 serum metabolites and the risk of ovarian cancer and its subtypes through Mendelian randomization analysis. 2. **Verify Directionality**: Conduct reverse Mendelian randomization analysis to verify whether the levels of serum metabolites are affected by the risk of ovarian cancer. 3. **Metabolic Pathway Analysis**: Use MetaboAnalyst 5.0 software to perform metabolic pathway analysis to identify metabolic pathways related to ovarian cancer and its subtypes. ### Main Findings - **Overall Results**: The study found 18 potential causal associations, involving 14 known metabolites, of which 8 are potential risk factors and 6 are potential cancer - risk - reducing factors. - **Specific Subtypes**: - **Mucinous Ovarian Cancer (MOC)**: 1,5 - Anhydroglucitol (1,5 - AG) and ADpSGEGDFXAEGGGVR are associated with an increased risk of MOC. - **Clear Cell Ovarian Cancer (OCCC)**: Betaine is associated with a reduced risk of OCCC, while estrone 3 - sulfate is associated with an increased risk of OCCC. - **Endometrioid Ovarian Cancer (OCED)**: 3-(3 - hydroxyphenyl)propionic acid, 1,5 - Anhydroglucitol (1,5 - AG), 1 - Linoleoyl - Glycerophosphoethanolamine and ADpSGEGDFXAEGGGVR are associated with an increased risk of OCED, while arachidonic acid (20:4n6) and stearidonic acid (18:4n3) are associated with a reduced risk of OCED. - **Serous Ovarian Cancer (SOC)**: X - 13183 - Stearamide and DSGEGDFXAEGGGVR are associated with a reduced risk of SOC, while 2 - Hydroxybenzoic acid (salicylate) is associated with a reduced risk of SOC. ### Conclusion This study reveals protective and risk - related metabolites through Mendelian randomization analysis, providing insights into the potential causal relationships between genetically determined metabolites and metabolic pathways related to ovarian cancer and its subtypes. These metabolites may be candidates for ovarian cancer biomarkers, which are helpful for the early detection, treatment and prevention of ovarian cancer.

Exploring the causal role of multiple metabolites on ovarian cancer: a two sample Mendelian randomization study

Causal association between 637 human metabolites and ovarian cancer: a mendelian randomization study

Unveiling the causal link between metabolic factors and ovarian cancer risk using Mendelian randomization analysis

Genetically predicted blood metabolites mediate relationships between gut microbiota and ovarian cancer: a Mendelian randomization study

Gut microbiota and risk of ovarian diseases: a two-sample Mendelian randomization study

Associations between serum metabolites and female cancers: A bidirectional two-sample mendelian randomization study

Association between gut microbiota, plasma metabolites, and ovarian cancer: A Mendelian randomization study

Causal Effects of Genetically Determined Metabolites on Risk of Polycystic Ovary Syndrome: A Mendelian Randomization Study

Non-targeted metabolomics revealed novel links between serum metabolites and primary ovarian insufficiency: a Mendelian randomization study

A metabolome-wide Mendelian randomization study prioritizes causal circulating metabolites for reproductive disorders including primary ovarian insufficiency, polycystic ovary syndrome, and abnormal spermatozoa

Causality of genetically determined metabolites on susceptibility to prevalent urological cancers: a two-sample Mendelian randomization study and meta-analysis

Causal association between metabolites and upper gastrointestinal tumors: A Mendelian randomization study

Appraising the Role of Circulating Concentrations of Micro-Nutrients in Epithelial Ovarian Cancer Risk: A Mendelian Randomization Analysis

Review of Mendelian Randomization Studies on Ovarian Cancer

Exploring the causal role of the human gut microbiome in endometrial cancer: a Mendelian randomization approach

Genetically identification of endometriosis and cancers risk in women through a two-sample Mendelian randomization study

Association of Smoking, Alcohol, and Coffee Consumption with the Risk of Ovarian Cancer and Prognosis: a Mendelian Randomization Study

Identification of circulating metabolites linked to the risk of breast cancer: a mendelian randomization study

Metabolome-Wide Mendelian Randomization Assessing the Causal Relationship Between Blood Metabolites and Primary Ovarian Insufficiency

Inferring Causal Relationships Between Metabolites and Polycystic Ovary Syndrome Using Summary Statistics from Genome‑Wide Association Studies

Endometriosis and epithelial ovarian cancer: a two-sample Mendelian randomization analysis